Dr. J. Razumien?: About Inflammatory Processes and Cooperation with Ukrainian Researchers

Dr. J. Razumien?: About Inflammatory Processes and Cooperation with Ukrainian Researchers

“Today, Ukrainian researchers are forced to continue their work in unimaginable conditions: some at subway stops, some virtually, or in other possible ways. Ukraine is an ambitious country,” says Dr. Julija Razumiene , a biochemist at Vilnius University Life Sciences Center (VU LSC).

The researcher has been working with Ukrainian scientists for a long time, but the Russian war has encouraged a strong desire to help scientists implement their ideas “here and now.”

In our conversation with Dr. Julija Razumien?, we have discussed one of her current scientific focuses: inflammatory processes and how researchers can support Ukraine's scientific community.

?

Q: Why is it important to identify inflammatory processes as early as possible?

A: Early detection of inflammatory processes is vital for timely treatment, predicting the outcome of the disease, and creating effective anti-inflammatory treatment.

First, analytical tests are necessary to quickly distinguish inflammatory diseases from noninflammatory ones, such as rheumatic diseases. Second, early identification of critical conditions such as sepsis allows rapid initiation of appropriate treatment, resulting in lower mortality and less severe long-term sequelae.

?

Q: Many advertisements now offer an anti-inflammatory diet or even supplements. How do you rate them?

A: In my opinion, intestinal microflora is essential for the body’s general condition. Therefore, all the supplements intended for the necessary microflora reproduction and high-fiber food will always be beneficial if used wisely.

However, it should be noted that this is simply a way of leading a healthy lifestyle. Alternatively, such supplements can benefit recovery after a severe treatment or during the postoperative period. Unfortunately, they will not be sufficient to treat a serious, long-lasting inflammatory process.

I’d also like to assure you that everyone is a unique organism. Currently, no methods can determine with great precision what combinations and quantity ratios of microorganisms are needed for one’s body, so we should not unquestioningly trust advertisements that offer the best options. I would advise you to listen to your body’s reaction after using one or another supplement.


LT-UA project LT implementers in the laboratory of the Bioanalysis Department, Biochemistry Institute, Life Sciences Center, Vilnius University. From the front Nijol? Baliuckien?, Marius Butkevi?ius, dr. Ieva ?akinyt?-Urbikien? ir Vidut? Gurevi?ien?.

Q: You were allocated funding to implement the Lithuanian-Ukrainian project “Biosensors of esterase activity for early diagnosis of inflammatory processes.” What is the importance of this project? What is your goal?

A: Undoubtedly, inflammatory processes directly affect our daily health, so the importance of early diagnosis of these processes can’t be overestimated.

Currently, tests for detecting inflammation are not very specific. For example, inflammation often increases blood levels of C-reactive protein (CRP) produced by the liver. Increased level of cholesterol is also associated with inflammatory processes but is improper for early diagnosis. It is possible to test inflammatory cytokines - IL-1, IL-6, IL-17, and - TNF-alpha, or factor kappa B (NF-kB). However, these tests are expensive, rare, and may not be performed in Lithuania.

Challenges in the early detection of inflammatory processes include limited analytical capacity and the great need to distinguish between patients with inflammatory and non-inflammatory diseases quickly. Recent studies in world literature indicate that when signs of inflammation occur, the activity of a group of enzymes called esterases increases in the body. Esterase’s activation is believed to be an essential aspect of physiological processes and drug metabolism in the human body.

Esterases detoxify a variety of toxic compounds, including cocaine, pesticides, aspirin, and other medicines. Modern research is focused on the diversity of esterases, their functions in various human tissues, and their role in drug metabolism. Still, there is no direct information about the activation mechanisms of esterases in living organisms.

The Bioanalysis Department at the VU LSC Institute of Biochemistry has extensive expertise in making enzymatic biosensors as bioanalysis tools. Thus, we have undertaken a task to develop diagnostic systems for inflammatory processes by analyzing the modifications in enzyme activity, specifically esterases. Due to the great diversity of these enzymes and their activity in various biological media, we hope to be able to develop more noninvasive diagnostic methods in which tests of saliva or urine samples replace blood or cerebrospinal fluids. We have many ambitious goals to find answers that explain the activation mechanisms of esterases in living organisms.


Q: At the conference “Modern Achievements of Experimental, Clinical, Environmental Biochemistry and Molecular Biology” held in Kharkiv (Ukraine), you presented many biosensors that can be used to study various pathologies associated with kidney, liver, or pancreatic dysfunctions. What are these dysfunctions and pathologies?

A: I accepted the offer to participate in the conference organized by the National University of Pharmacy in Kharkiv (Ukraine) in the organizational committee with great respect. Especially since my colleagues and I have developed many biosensors, and we can publicize their usefulness in developing new diagnostic/prognostic methods.

Among the biosensors for studying kidney, liver, or pancreas dysfunctions, perhaps the newest biosensor is designed to determine glutamate in various biological media: cerebrospinal fluid, blood, or urine.

Inexpensive, easily performed tests of glutamate concentrations alone would be crucial because glutamate pathologies are associated with many neurological disorders: amyotrophic or multiple sclerosis, Alzheimer’s, Parkinson’s, Huntington's diseases, stroke, chronic fatigue syndrome, insomnia, or mental exhaustion.


Dr. Ieva ?akinyt?-Urbikien? and Marius Butkevi?ius, young researchers of the project, are testing the newly developed biosensors

Q: Returning to your projects with Ukrainian researchers, how is science going in Ukraine now?

A: Ukraine is an ambitious country. Despite the conditions caused by the Russian war, most scientific and educational institutions continue their work at subway stops, online, or in other possible ways.

We already had common interests with Ukrainian researchers, and we used to meet at international conferences and discuss the possibilities of joint topics. However, it was Russia’s acts of aggression that prompted action as quickly and as widely as possible.

First, the VU LSC found opportunities to employ several temporarily emigrated researchers whose research fields did not directly match ours, but it allowed them to learn the specifics of our work and encouraged the search for relevant interdisciplinary solutions for both countries.

The Research Council of Lithuania | Lietuvos mokslo taryba initiated the call for applications in the Lithuanian-Ukrainian Cooperation Programme in the Fields of Research and Technologies, and we received funding to research this topic. Ukrainian researchers also received their financial share, albeit a much poorer one.

The situation in Ukraine is now very complicated. Just imagine what happens when the electricity and the Internet are cut off. I would say that everything is happening only because of endless Ukrainian endurance, stubbornness, and ingenuity. Our partners also have to work at night, and some project participants are working just a few kilometers from the front line. His colleagues from the entire department joke that they are constantly sending him not only wishes but also food and clothes.

On the other hand, the war also raised new issues that are being successfully addressed by Ukraine’s partners, such as various inflammations caused by war injuries. It was very pleasant to hear that the conference report on a new type of patch promoting faster wound healing was presented at the aforementioned conference, and it interested not only Ukrainian surgeons.

"Science will be developed in any conditions, even the most difficult ones, as long as researchers are dedicated to their cause, " - says Dr. J. Razumien?.


Read more about the difference between acute and chronic inflammatory processes, glucose tests' accuracy, and how Lithuanian-Ukrainian scientists' collaboration works in reality in Dr. Julija Razumien?'s full interview on the VU LSC website: https://www.gmc.vu.lt/en/about/news/3629-dr-j-razumiene-about-inflammatory-processes-and-cooperation-with-ukrainian-researchers.


?

Interviewed by Goda Raibyt?-Aleksa ??

Photo credits: Dr. Julija Razumien?'s personal archive

要查看或添加评论,请登录

Vilnius University Life Sciences Center的更多文章

社区洞察

其他会员也浏览了